Less Ads, More Data, More Tools Register for FREE

Pin to quick picksParvus En Regulatory News (AEET)

Share Price Information for Parvus En (AEET)

Share Price is delayed by 15 minutes
Get Live Data
25.00    0.00 (0.00%)
Bid:
23.00
Ask:
27.00
Spread: 4.00 (17.391%)
Market Cap: £20.36m
AEET Live PriceLast checked at - London Stock Exchange

Intraday Parvus En Share Chart

New management arrangements

13 Apr 2026 07:00

RNS Number : 0759A
Aquila Energy Efficiency Trust PLC
13 April 2026
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION.

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

 

13 April 2026

Aquila Energy Efficiency Trust PLC (the "Company")

New management arrangements

Highlights

· Transition to a self-managed alternative investment fund

· Termination of arrangements with Aquila Capital as investment adviser and Fundrock as AIFM

· Retention of services of Alex Betts and Franco Hauri (via his personal service company, Truenorth Value Partners GmbH) as consultants to the Company

Self-management and new consultancy arrangements

The Company announces that having made a successful application to the Financial Conduct Authority (the "FCA"), it has been entered onto the FCA register of small registered UK AIFMs and, from 10 April 2026, is operating as a small, selfmanaged alternative investment fund. The Company intends to remain self-managed for the remainder of its wind-down process.

Following constructive discussions between Aquila Capital and the Board starting in 2025, the Board considered all options regarding the ongoing management of the Company and its assets, for the remainder of its managed wind-down process. The Board considered its options, in particular, in the context of its annual requirement, pursuant to the FCA's UK Listing Rules, as to whether the continuing appointment of Aquila Capital on the terms agreed was in the best interests of the Company's shareholders as a whole.

The Board acknowledges Aquila Capital's role as investment adviser in relation to the Company since its IPO in 2021.

Of note in this consideration, the Company's portfolio, comprises 21 assets that are geographically diverse, small in size, contractually complex and many have lengthy maturities of between ten to 18 years.

The Board has therefore agreed:

- mutually with Aquila Capital that the investment advisory agreement with Aquila Capital ("Investment Advisory Agreement") has terminated with effect from 10 April 2026, with no payment in lieu of notice;

- to appoint as consultants to the Company, both Alex Betts and Truenorth Value Partners GmbH ("Truenorth Value Partners") (the personal service company of Franco Hauri) (together the "Consultants"), the two individuals who, as part of Aquila Capital, have been principally responsible for managing the investment portfolio at Aquila Capital since IPO in 2021 and assisting the Board in the preparation of the Company's financial reports; and

- that the Alternative Investment Fund Manager agreement with Fundrock ("AIFM Agreement") has terminated with effect from 10 April 2026.

The Company has entered into a consultancy agreement with Alex Betts and Truenorth Value Partners ("Consultancy Agreement"). Under the Consultancy Agreement:

- the Consultants will inter alia assist with the realisation strategies for the Company's investments as well as their ongoing management; 

- the Consultants are entitled to receive a base fee of £550,000 per annum in aggregate for an initial period of 18 months, reducing to £300,000 once either (i) the number of assets is five or fewer or (ii) aggregate asset NAV is £5 million or less;

- the Consultants will receive a performance fee on each disposal calculated by reference to the value realised as a percentage of the relevant asset's net asset value ("Asset NAV"), as follows:

i. 2 per cent of the value realised where such value exceeds 90 per cent of the Asset NAV;

ii. 1.75 per cent of the value realised where such value is between 80 per cent and 90 per cent of the Asset NAV; and

iii. 1 per cent of the value realised where such value is less than 80 per cent of the Asset NAV" of between 1 per cent and 2 per cent of the value of each asset disposed of, depending on the net value realised as a result of the disposal; and

- no performance fee payments will be released until a further £15 million of value has been realised through disposals of assets. In addition, while 50% of any performance fee in respect of an asset will be paid shortly after disposal, subject to the value received meeting a hurdle, the balance will be retained by the Company until the Company no longer has any remaining assets or payments due to be received on any assets.

The rationale for the Company entering into the Consultancy Agreement is that it retains the Aquila Capital individuals who were allocated by Aquila Capital to deliver Aquila Capital's investment advisory services since the Company's inception. Alex Betts and Franco Hauri will provide their services to the Company under the Consultancy Agreement on that basis. This will allow continuity of knowledge of the complex assets that comprise the portfolio. Accordingly, as of 10 April 2026, Aquila Capital no longer has an ongoing role as investment adviser to the Company.

The Board believes that the new investment management arrangements which no longer require an external AIFM, provide for the continued involvement of key persons who have been managing the Company's complex assets and who are incentivised to complete the Company's managed run off, which will enter its fourth year in June this year.

 

For further information, please contact:

Miriam Greenwood (Chair) Via Burson Buchanan

Canaccord Genuity Limited (Corporate Broker)

Edward Gibson-Watt

 

+44 20 7523 8000

Buchanan (Financial PR)

Henry Wilson, Helen Tarbet, Nick Croysdill

henry.wilson@bursonbuchanan.com

Apex Listed Companies Services (UK) Limited (Company Secretary)

 

+44 20 3327 9720

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014, as it forms part of UK domestic law ("MAR"). Upon publication of this announcement, the inside information is now considered to be in the public domain for the purposes of MAR. The person responsible for arranging the release of this announcement on behalf of the Company is Grace Goudar of Apex Listed Companies Services (UK) Limited.

The Company's LEI is 213800AJ3TY3OJCQQC53.

This announcement may contain forward‑looking statements. Forward‑looking statements include, without limitation, statements containing the words "anticipate", "believe", "intend", "estimate", "project", "forecast", "plan", "expect", "will", "could", "may", "might", or words of a similar meaning. By their nature, forward‑looking statements involve risk and uncertainty because they relate to future events and circumstances, including, without limitation, the Company's wind‑down and realisation strategies, values and timing achieved on disposals, future management arrangements and related fees and costs. Actual outcomes and results may differ materially from any outcomes or results expressed or implied by such forward‑looking statements. Nothing in this announcement is intended to be, or to be construed as, a profit forecast. Forward‑looking statements speak only as of the date of this announcement and the Company undertakes no obligation to update them except as required by applicable law or regulation.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCGZGMDRGRGVZM
Date   Source Headline
9th May 20247:00 amRNSNotice of AGM
3rd May 20242:13 pmRNSAnnual Report and Accounts
30th Apr 20243:04 pmRNSAnnual Financial Report
19th Apr 20249:55 amRNSProposed Tender Offer
6th Mar 20242:45 pmRNSUnaudited NAV and Return of Capital
19th Jan 20242:00 pmRNSUpdate re: Investment Adviser
16th Nov 202310:54 amRNSDirector Declaration
27th Sep 20237:00 amRNSHalf-year Report
25th Sep 20234:00 pmRNSHolding(s) in Company
16th Aug 20237:00 amRNSShareholder Update
11th Aug 20237:00 amRNSNet Asset Value as at 30 June 2023
14th Jun 20235:21 pmRNSResult of AGM
2nd May 20237:01 amRNSNotice of AGM
2nd May 20237:00 amRNSFinal Results
13th Apr 20231:28 pmRNSDirector/PDMR Shareholding
15th Mar 20237:00 amRNSAppointment of Sole Corporate Broker
28th Feb 20233:36 pmRNSResult of General Meeting
27th Feb 20231:24 pmRNSGeneral Meeting Update on Proxy Votes
20th Feb 20237:00 amRNSPurchase of shares in relation to inv.advisory fee
16th Feb 20237:01 amRNSDividend Declaration
16th Feb 20237:00 amRNSNAV and Fact Sheet as at 31 December 2022
13th Feb 20237:00 amRNSPublication of Circular
30th Jan 20237:00 amRNSPositive Investment Update
17th Jan 20237:00 amRNSChange of Name of Company Secretary
20th Dec 20225:32 pmRNSDirector/PDMR Shareholding
20th Dec 20227:00 amRNSTrading Update
13th Dec 20224:03 pmRNSDirector/PDMR Shareholding
3rd Nov 20225:31 pmRNSChange of AIFM's Name
3rd Nov 20227:00 amRNSDividend Declaration
2nd Nov 202211:58 amRNSAppointment of Non-executive Director
15th Sep 20224:22 pmRNSPurchase of shares re investment advisory fees
15th Sep 20227:00 amRNSDividend Declaration
15th Sep 20227:00 amRNSHalf-year Report
12th Aug 20225:55 pmRNSHolding(s) in Company
12th Aug 20227:00 amRNSFactsheet as at 30 June 2022
12th Aug 20227:00 amRNSNet Asset Value(s)
25th Jul 20222:06 pmRNSResult of General Meeting
25th Jul 20227:00 amRNSTrading Update
29th Jun 20225:03 pmRNSDirector/PDMR Shareholding
28th Jun 20224:30 pmRNSResult of AGM
28th Jun 20224:06 pmRNSPurchase of shares re investment advisory fees
24th Jun 20227:00 amRNSAnnual Financial Report
1st Jun 20227:00 amRNSNotice of AGM
29th Apr 20227:00 amRNSAppointment of Non-executive Director
21st Apr 20227:00 amRNSResult of Investment Strategy Review
23rd Feb 20223:15 pmRNSHolding(s) in Company
17th Feb 20227:00 amRNSFactsheet as at 31 December 2021
31st Jan 20227:00 amRNSCompany Update
6th Dec 20214:55 pmRNSChange of Registered Office
21st Oct 20217:00 amRNSReduction of the share premium account

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.